Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BioClinica Names David Peters New CFO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

BioClinica Names David Peters New CFO

Replaces Ted Kaminer who is retiring

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BioClinica, a specialty clinical trials services and technology provider, has named David Peters executive vice president and chief financial officer. He will be joining BioClinica on June 8, 2015.

Mr. Peters brings more than 25 years of financial and accounting experience with a focus in pharmaceutical services.

“David has extensive and deep knowledge in all areas of finance, accounting and business operations and understands the specifics of our high growth and diverse business segments in both private and public markets, making him well-suited for the position,” said BioClinica chief executive officer, John Hubbard.

Mr. Peters has directed all facets of accounting, financial functions and strategy in global businesses and has successfully negotiated more than 20 strategic partnership agreements. He was most recently chief financial officer at WCCT Global where he developed the strategic plan, successfully positioning the contract research organization for growth and investment. 

Mr. Peters replaces executive vice president and chief financial officer Ted Kaminer, who is retiring after 12 years with the company.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics